Free Trial
CVE:GSD

Devonian Health Group (GSD) Stock Price, News & Analysis

C$0.12 -0.01 (-3.85%)
(As of 11/19/2024 05:34 PM ET)

About Devonian Health Group Stock (CVE:GSD)

Key Stats

Today's Range
C$0.13
C$0.13
50-Day Range
C$0.11
C$0.16
52-Week Range
C$0.08
C$0.35
Volume
7,500 shs
Average Volume
19,924 shs
Market Capitalization
C$18.53 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine, completed Phase IIa clinical trial product for the treatment of ulcerative colitis and atopic dermatitis. The company also develops Pantoprazole Magnesium for the treatment of gastric; Cleo-35 for the treatment of hormonal acne in women; and value-added products for dermo-cosmetics. In addition, the company acquires drug and health product licenses; and distributes pharmaceutical products. Devonian Health Group Inc. was incorporated in 2015 and is headquartered in Québec, Canada.

Receive GSD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Devonian Health Group and its competitors with MarketBeat's FREE daily newsletter.

GSD Stock News Headlines

Breaking News: Tesla headed to $500…
That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.
Devonian Health Group Inc.
See More Headlines

GSD Stock Analysis - Frequently Asked Questions

Devonian Health Group's stock was trading at C$0.15 at the beginning of 2024. Since then, GSD stock has decreased by 13.8% and is now trading at C$0.13.
View the best growth stocks for 2024 here
.

Shares of GSD stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
Computer Software
CIK
N/A
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

Net Income
C$-3,170,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$9.75 million
Cash Flow
C$0.02 per share
Book Value
C$0.09 per share

Miscellaneous

Free Float
N/A
Market Cap
C$18.53 million
Optionable
Not Optionable
Beta
1.28
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (CVE:GSD) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners